The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR).
US FDA's IDE approval allows the MagicTouch SCB to be used in a pivotal clinical study to support safety and effectiveness of this combination product. The data generated from this IDE clinical study will support a pre-market approval (PMA) application in the USA.
MagicTouch SCB is the world's first Sirolimus-coated Balloon with extensive commercial usage in Europe, major markets of Asia and the Mid-Eastern markets. More than 100 thousand patients have been treated with MagicTouch SCB in these markets.
About MagicTouch SCB:
MagicTouch SCB is a CE marked and commercially marketed Sirolimus coated balloon developed by Concept Medical, using proprietary Nanolute Technology. MagicTouch SCB has been used in >50,000 patients in major global markets.
About Concept Medical Inc (CMI):
CMI is headquartered in Tampa, Florida and has operational offices in The Netherlands, Singapore and Brazil and manufacturing units in India. CMI specializes in developing drug-delivery systems and has unique and patented technology platforms that can be deployed to deliver any drug / pharmaceutical agent across the luminal surfaces of blood vessels.
www.conceptmedical.com
Photo - https://mma.prnewswire.com/media/1901255/MagicTouch.jpg
Logo - https://mma.prnewswire.com/media/1244676/Concept_Medical_Logo.jpg
Letters from the past อัลบั้มที่เต็มไปด้วยเรื่องราวจากความทรงจำของ Le Fronce เปิดตัวด้วยเพลง "รูปถ่าย (Polaroid)" ได้ บิลลี่ Tilly Birds ร่วมแต่ง
Bangchak Wins Outstanding Human Rights Role Model Organization Award for Third Consecutive Year Committed to Business Operations Founded on Respect, Inclusivity, and Equality
บางจากฯ รับรางวัลองค์กรต้นแบบด้านสิทธิมนุษยชน ต่อเนื่องเป็นปีที่ 3 ยึดมั่นการดำเนินธุรกิจบนพื้นฐานแห่งความเคารพ เปิดกว้าง เท่าเทียม